Jagsonpal Pharmaceuticals has informed that the Nomination and Remuneration Committee today approved the grant of 10,47,920 employee stock options under the company’s Employees Stock Option Plan, 2022 at an exercise price of Rs 235 per option. The said options, which are convertible into equivalent number of equity shares of Rs 5.00 each, will vest in 4 equal annual tranches commencing from the first anniversary of the grant.
The above information is a part of company’s filings submitted to BSE.
